
Apiject Submits Innovative Prefilled Single Dose Injection Device for FDA Approval
STAMFORD, Conn., Sept. 25, 2025 /PRNewswire/ — Today Apiject Systems, Corp. (Apiject, www.apiject.com) announced its submission for regulatory approval of its New Drug Application (NDA) to the Food and Drug Administration (FDA) for the world’s first injectable medicine to use Apiject’s single dose, single use prefilled plastic syringe.








